🇺🇸 FDA
Pipeline program

Epidyolex 100 mg/ml oral solution

JZP926-402

Approved small_molecule active

Quick answer

Epidyolex 100 mg/ml oral solution for Tuberous Scerlosis Complex is a Approved program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Tuberous Scerlosis Complex
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials